Insider Trading activities of Arena Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arena Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arena Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Arena Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ARNA. The reporting company's CIK number is 1080709.
The total value of stock buying since 2005 is $776,061.
The total value of stock sales since 2005 is $12,351,104.
The total value of stock option exercises since 2005 is $4,791,844.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Arena Pharmaceuticals Inc (ARNA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-05 25,000 $29,750 0 $0 0 $0
2017-04 50,000 $70,500 0 $0 0 $0
2016-06 0 $0 18,728 $37,306 0 $0
2015-03 0 $0 146,268 $692,290 271,268 $406,999
2015-01 0 $0 95,000 $556,200 95,000 $351,700
2014-09 0 $0 0 $0 100,000 $149,000
2014-07 0 $0 223,525 $1,308,515 0 $0
2014-06 0 $0 2,473 $14,467 2,473 $13,502
2014-05 0 $0 49,176 $346,572 49,176 $85,048
2014-04 0 $0 133,805 $844,842 133,805 $721,385
2014-03 0 $0 25,000 $175,275 25,000 $37,250
2014-01 0 $0 221,666 $1,529,962 221,666 $1,329,996
2013-11 0 $0 20,000 $103,720 20,000 $29,800
2013-09 0 $0 220,000 $1,391,719 220,000 $359,800
2013-05 0 $0 83,750 $670,000 83,750 $129,393
2013-04 0 $0 71,250 $585,105 71,250 $128,962
2012-10 0 $0 50,000 $416,000 50,000 $74,000
2012-07 0 $0 166,665 $1,677,496 136,665 $511,201
2012-03 0 $0 10,800 $32,670 6,250 $9,312
2012-02 30 $57 0 $0 0 $0
2010-01 0 $0 0 $0 27,500 $16,500
2009-05 123,300 $328,486 0 $0 0 $0
2009-02 0 $0 0 $0 60,000 $36,000
2008-09 0 $0 10,000 $61,640 0 $0
2008-06 20,000 $93,740 0 $0 0 $0
2008-05 30,000 $154,050 0 $0 0 $0
2007-10 0 $0 35,000 $372,675 0 $0
2007-09 0 $0 5,000 $57,950 0 $0
2007-03 0 $0 63,552 $712,583 58,552 $218,996
2006-08 0 $0 10,000 $103,930 0 $0
2006-07 0 $0 7,500 $78,637 5,000 $3,000
2006-03 0 $0 30,000 $581,550 30,000 $180,000
2005-09 11,100 $99,478 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Arena Pharmaceuticals Inc insiders (ARNA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-05-12 Munshi Amit (President and CEO) Buy 25,000 1.19 29,750
2017-04-26 Munshi Amit (President and CEO) Buy 50,000 1.41 70,500
2016-06-13 White Christine Anna (Director) Sale 18,728 1.99 37,306
2015-03-30 Woods Randall E (Director) Sale 76,268 4.49 342,290
2015-03-30 Woods Randall E (Director) Option Ex 76,268 1.38 105,249
2015-03-17 Spector Steven W (EVP, General Counsel & Sec) Sale 70,000 5.00 350,000
2015-03-17 Spector Steven W (EVP, General Counsel & Sec) Option Ex 70,000 1.65 115,500
2015-03-03 Lief Jack (President and CEO) Option Ex 125,000 1.49 186,250
2015-01-08 Spector Steven W (EVP, General Counsel & Sec) Sale 45,000 6.26 281,700
2015-01-08 Spector Steven W (EVP, General Counsel & Sec) Option Ex 45,000 6.16 277,200
2015-01-07 Shanahan William R Jr (SVP & Chief Medical Officer) Sale 50,000 5.49 274,500
2015-01-07 Shanahan William R Jr (SVP & Chief Medical Officer) Option Ex 50,000 1.49 74,500
2014-09-17 Lief Jack (Chairman, President and CEO) Option Ex 100,000 1.49 149,000
2014-07-01 Lief Jack (Chairman, President and CEO) Sale 223,525 5.85 1,308,515
2014-06-27 Belcher Donald D (Director) Sale 2,473 5.85 14,467
2014-06-27 Belcher Donald D (Director) Option Ex 2,473 5.46 13,502
2014-05-12 Spector Steven W (EVP, General Counsel & Sec) Sale 45,000 7.05 317,340
2014-05-12 Spector Steven W (EVP, General Counsel & Sec) Option Ex 45,000 1.49 67,050
2014-05-06 Belcher Donald D (Director) Sale 4,176 7.00 29,232
2014-05-06 Belcher Donald D (Director) Option Ex 4,176 4.31 17,998
2014-04-22 Hixson Harry F Jr (Director) Sale 36,900 6.31 232,765
2014-04-22 Hixson Harry F Jr (Director) Option Ex 36,900 4.11 151,659
2014-04-14 Nova Tina Susan (Director) Sale 35,000 6.22 217,770
2014-04-14 Nova Tina Susan (Director) Option Ex 35,000 5.13 179,725
2014-04-01 Belcher Donald D (Director) Sale 1,905 6.45 12,287
2014-04-01 Belcher Donald D (Director) Option Ex 1,905 6.30 12,001
2014-04-01 Shanahan William R Jr (SVP & Chief Medical Officer) Sale 60,000 6.37 382,020
2014-04-01 Shanahan William R Jr (SVP & Chief Medical Officer) Option Ex 60,000 6.30 378,000
2014-03-04 Spector Steven W (EVP, General Counsel & Sec) Sale 25,000 7.01 175,275
2014-03-04 Spector Steven W (EVP, General Counsel & Sec) Option Ex 25,000 1.49 37,250
2014-01-17 Lief Jack (Chairman, President and CEO) Sale 100,000 7.81 781,300
2014-01-17 Lief Jack (Chairman, President and CEO) Option Ex 100,000 6.00 600,000
2014-01-10 Behan Dominic P (EVP & Chief Scientific Officer) Sale 33,332 6.25 208,325
2014-01-10 Behan Dominic P (EVP & Chief Scientific Officer) Option Ex 33,332 6.00 199,992
2014-01-09 Bice Scott H (Director) Sale 25,000 6.10 152,500
2014-01-09 Bice Scott H (Director) Option Ex 25,000 6.00 150,000
2014-01-09 Belcher Donald D (Director) Sale 30,000 6.15 184,500
2014-01-09 Belcher Donald D (Director) Option Ex 30,000 6.00 180,000
2014-01-09 Spector Steven W (EVP, General Counsel & Sec) Sale 33,334 6.10 203,337
2014-01-09 Spector Steven W (EVP, General Counsel & Sec) Option Ex 33,334 6.00 200,004
2013-11-12 Spector Steven W (EVP, General Counsel & Sec) Sale 20,000 5.19 103,720
2013-11-12 Spector Steven W (EVP, General Counsel & Sec) Option Ex 20,000 1.49 29,800
2013-09-10 Behan Dominic P (EVP & Chief Scientific Officer) Sale 200,000 6.30 1,261,000
2013-09-10 Behan Dominic P (EVP & Chief Scientific Officer) Option Ex 200,000 1.65 330,000
2013-09-05 Spector Steven W (EVP, General Counsel & Sec) Sale 20,000 6.54 130,719
2013-09-05 Spector Steven W (EVP, General Counsel & Sec) Option Ex 20,000 1.49 29,800
2013-05-21 Audet Craig Michael (SVP, Opn & Head Glob Reg Afrs) Sale 83,750 8.00 670,000
2013-05-21 Audet Craig Michael (SVP, Opn & Head Glob Reg Afrs) Option Ex 83,750 1.54 129,393
2013-04-01 Hoffman Robert (SVP, Finance and CFO) Sale 71,250 8.21 585,105
2013-04-01 Hoffman Robert (SVP, Finance and CFO) Option Ex 71,250 1.81 128,962
2012-10-01 Hoffman Robert (SVP, Finance and CFO) Sale 50,000 8.32 416,000
2012-10-01 Hoffman Robert (SVP, Finance and CFO) Option Ex 50,000 1.48 74,000
2012-07-05 Hoffman Robert (SVP, Finance and CFO) Sale 10,000 11.00 110,000
2012-07-03 Spector Steven W (EVP, General Counsel & Sec) Sale 22,300 10.05 224,115
2012-07-03 Spector Steven W (EVP, General Counsel & Sec) Option Ex 22,300 4.01 89,423
2012-07-02 Spector Steven W (EVP, General Counsel & Sec) Sale 134,365 10.00 1,343,381
2012-07-02 Spector Steven W (EVP, General Counsel & Sec) Option Ex 114,365 3.69 421,778
2012-03-29 Bielasz Jennifer Kathleen (Sr.Dir. of Acct. & Cont. (PAO)) Sale 10,800 3.02 32,670
2012-03-29 Bielasz Jennifer Kathleen (Sr.Dir. of Acct. & Cont. (PAO)) Option Ex 6,250 1.49 9,312
2012-02-01 Bielasz Jennifer Kathleen (Sr.Dir. of Acct. & Cont. (PAO)) Buy 30 1.90 57
2010-01-28 Behan Dominic P (SVP & Chief Scientific Officer) Option Ex 27,500 .60 16,500
2009-05-14 White Christine Anna (Director) Buy 20,000 2.69 53,860
2009-05-14 Bice Scott H (Director) Buy 3,800 2.67 10,146
2009-05-14 Belcher Donald D (Director) Buy 35,000 2.62 91,700
2009-05-14 Hixson Harry F Jr (Director) Buy 60,000 2.67 160,440
2009-05-14 Woods Randall E (Director) Buy 1,000 2.75 2,750
2009-05-14 Laforce James (Director) Buy 3,500 2.74 9,590
2009-02-09 Behan Dominic P (SVP & Chief Scientific Officer) Option Ex 60,000 .60 36,000
2008-09-02 Hoffman Robert (VP, Finance and CFO) Sale 10,000 6.16 61,640
2008-06-10 Hixson Harry F Jr (Director) Buy 20,000 4.69 93,740
2008-05-21 Schneider Phillip M (Director) Buy 10,000 5.04 50,450
2008-05-13 Belcher Donald D (Director) Buy 10,000 5.18 51,800
2008-05-13 Laforce James (Director) Buy 10,000 5.18 51,800
2007-10-19 Deerfield Partners, Lp (10% Owner) Sale 25,000 10.51 262,675
2007-10-01 Spector Steven W (SVP, General Counsel & Sec) Sale 10,000 11.00 110,000
2007-09-26 Scotti Louis J (VP, Marketing and Business Dev) Sale 5,000 11.59 57,950
2007-03-20 Behan Dominic P (SVP & Chief Scientific Officer) Option Ex 25,000 .60 15,000
2007-03-15 Behan Dominic P (SVP & Chief Scientific Officer) Sale 58,552 11.20 655,958
2007-03-15 Behan Dominic P (SVP & Chief Scientific Officer) Option Ex 33,552 6.08 203,996
2007-03-14 Scotti Louis J (VP, Marketing and Business Dev) Sale 5,000 11.32 56,625
2006-08-01 Scotti Louis J (VP, Marketing and Business Dev) Sale 10,000 10.39 103,930
2006-07-31 Hoffman Robert (VP, Finance and CFO) Sale 7,500 10.48 78,637
2006-07-31 Hoffman Robert (VP, Finance and CFO) Option Ex 5,000 .60 3,000
2006-03-06 Ajit-simh K A (VP, Quality Systems) Sale 20,000 19.39 387,700
2006-03-06 Ajit-simh K A (VP, Quality Systems) Option Ex 20,000 6.00 120,000
2005-09-26 Bice Scott H (Director) Buy 1,100 8.98 9,878
2005-09-21 Hixson Harry F Jr (Director) Buy 10,000 8.96 89,600

Insider trading activities including stock purchases, stock sales, and option exercises of ARNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arena Pharmaceuticals Inc (symbol ARNA, CIK number 1080709) see the Securities and Exchange Commission (SEC) website.